0,909  0,001  Adenosine deaminase inhibitor
0,891  0,003  Cytostatic
0,878  0,002  DNA synthesis inhibitor
0,862  0,001  Antineoplastic antimetabolite
0,814  0,002  Adenosine A1 receptor antagonist
0,799  0,001  NADH dehydrogenase inhibitor
0,795  0,001  Thymidine kinase inhibitor
0,751  0,002  RNA-directed DNA polymerase inhibitor
0,726  0,003  Cyclic AMP phosphodiesterase inhibitor
0,698  0,002  Adenosine A2 receptor antagonist
0,700  0,016  Teratogen
0,680  0,000  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,680  0,005  Cardioprotectant
0,658  0,002  Adenosine A3 receptor antagonist
0,665  0,018  Embryotoxic
0,643  0,002  Adenosine A2a receptor antagonist
0,644  0,011  Vasodilator, peripheral
0,632  0,002  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,621  0,001  Carbamoyl phosphate synthetase inhibitor
0,615  0,004  Cytidine deaminase inhibitor
0,614  0,005  Antineoplastic (osteosarcoma)
0,612  0,005  Antineoplastic enhancer
0,610  0,004  Adenylate cyclase inhibitor
0,608  0,004  Antiviral (Herpes)
0,613  0,011  Proliferative diseases treatment
0,596  0,002  Glutamate dehydrogenase inhibitor
0,595  0,002  Antiviral (Poxvirus)
0,607  0,020  Antineoplastic (solid tumors)
0,593  0,017  Immunostimulant
0,581  0,013  Immunomodulator
0,566  0,007  Antineoplastic (lymphoma)
0,560  0,007  Antineoplastic (non-Hodgkin's lymphoma)
0,552  0,002  DNA repair enzyme inhibitor
0,550  0,002  Phosphofructokinase-1 inhibitor
0,555  0,010  Vasodilator, coronary
0,560  0,016  Cytotoxic
0,532  0,001  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,532  0,002  UDP-glucose 4-epimerase inhibitor
0,532  0,004  DNA polymerase I inhibitor
0,528  0,005  DNA methylase inhibitor
0,537  0,022  Antineoplastic (myeloid leukemia)
0,512  0,006  Radiosensitizer
0,506  0,002  Xanthine oxidase substrate
0,505  0,002  Antimetabolite
0,505  0,006  Antiviral (Hepatitis)
0,497  0,009  Interleukin agonist
0,506  0,039  Antileukemic
0,496  0,034  Immunosuppressant
0,457  0,002  Adenylate kinase inhibitor
0,478  0,024  Chemoprotective
0,453  0,002  Argininosuccinate synthase inhibitor
0,452  0,002  Biliverdin reductase inhibitor
0,443  0,005  Antiviral (Hepatitis C)
0,435  0,004  Hexokinase inhibitor
0,422  0,002  Phosphoglycerate kinase inhibitor
0,410  0,002  Fumarate hydratase inhibitor
0,396  0,002  Nicotinic acid receptor 1 agonist
0,398  0,007  Antiviral (Hepatitis B)
0,394  0,005  Aldehyde dehydrogenase inhibitor
0,444  0,059  Antibacterial
0,391  0,010  DNA methyltransferase I inhibitor
0,402  0,029  Hypoxia-inducible factor 1 alpha inhibitor
0,405  0,038  Radioprotector
0,387  0,021  Antineoplastic (lymphocytic leukemia)
0,363  0,005  Aminoacyl-tRNA synthetase inhibitor
0,364  0,009  Antidiabetic (type 1)
0,356  0,002  Adenosine A1 receptor agonist
0,372  0,028  Vasodilator
0,353  0,009  Acute respiratory distress syndrome (ARDS) treatment
0,345  0,002  Antiviral (Herpesvirus 3, Human)
0,343  0,004  Antiviral (Influenza B)
0,342  0,004  Ornithine carbamoyltransferase inhibitor
0,357  0,020  Antiviral (HIV)
0,331  0,001  Adenosine kinase inhibitor
0,370  0,049  Antimycobacterial
0,371  0,052  ICAM1 expression inhibitor
0,339  0,021  Antiviral (Influenza)
0,352  0,037  Cardiodepressant
0,326  0,011  Alkylator
0,362  0,051  Antiischemic
0,312  0,002  Equilibrative nucleoside transport protein inhibitor
0,361  0,053  Respiratory analeptic
0,326  0,017  Peptidyltransferase inhibitor
0,305  0,005  Phosphodiesterase I inhibitor
0,312  0,015  Alpha-N-acetylglucosaminidase inhibitor
0,294  0,006  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,284  0,001  Thymidine phosphorylase inhibitor
0,273  0,002  Purinergic P2X1 antagonist
0,267  0,004  Neutropenia treatment
0,298  0,035  Septic shock treatment
0,384  0,121  Caspase 9 stimulant
0,322  0,060  Interleukin 2 agonist
0,263  0,002  Acyl-CoA dehydrogenase inhibitor
0,262  0,008  Antiviral (Ebola)
0,326  0,075  Cholesterol antagonist
0,252  0,002  Adenosine A3 receptor agonist
0,253  0,003  Antiviral (Dengue virus)
0,264  0,015  Topoisomerase I inhibitor
0,270  0,023  Diabetic nephropathy treatment
0,268  0,021  Antiviral (West Nile virus)
0,267  0,021  Cystic fibrosis treatment
0,248  0,004  Adenylate cyclase stimulant
0,267  0,022  Protein kinase stimulant
0,312  0,068  Analeptic
0,242  0,004  Adenosine A2b receptor antagonist
0,306  0,068  Antineoplastic (endocrine cancer)
0,238  0,000  Hypoxanthine phosphoribosyltransferase inhibitor
0,310  0,079  Apoptosis antagonist
0,315  0,087  Transcription factor NF kappa B inhibitor
0,271  0,049  Mutagenic
0,223  0,001  AICAR transformylase inhibitor
0,238  0,019  Aldose reductase substrate
0,289  0,071  Antituberculosic
0,221  0,004  Phosphorylase inhibitor
0,225  0,010  Antiviral (CMV)
0,212  0,011  Aldehyde dehydrogenase substrate
0,334  0,134  Cyclophilin D inhibitor
0,334  0,134  Antidiabetic
0,269  0,070  Cardiotonic
0,246  0,048  Antialcoholic
0,282  0,084  NOS3 expression inhibitor
0,259  0,066  Angiogenesis stimulant
0,228  0,035  Amylase inhibitor
0,192  0,001  Adenosine A2 receptor agonist
0,285  0,099  Antithrombotic
0,187  0,002  Nucleoside transporters inhibitor
0,308  0,125  TNF expression inhibitor
0,191  0,008  Heat shock protein 70 antagonist
0,282  0,099  Antineoplastic (small cell lung cancer)
0,181  0,001  Purine nucleoside phosphorylase inhibitor
0,178  0,001  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,272  0,100  Antineoplastic (brain cancer)
0,196  0,025  MAP kinase 3 inhibitor
0,184  0,014  Alcohol dehydrogenase inhibitor
0,227  0,058  Platelet adhesion inhibitor
0,190  0,022  Xanthine oxidase inhibitor
0,182  0,015  Chronic obstructive bronchitis treatment
0,181  0,018  Antineoplastic, alkylator
0,174  0,015  Carcinogenic, group 2A
0,318  0,160  Apoptosis agonist
0,164  0,007  Phosphodiesterase 6D inhibitor
0,241  0,086  DNA damaging
0,165  0,010  Ribonucleotide reductase inhibitor
0,216  0,062  UDP-glucuronosyltransferase substrate
0,180  0,029  Antiprotozoal (Trichomonas)
0,205  0,058  Antianginal
0,250  0,104  Metabolic disease treatment
0,207  0,067  Carcinogenic
0,142  0,003  S-adenosyl-L-homocysteine hydrolase inhibitor
0,186  0,049  Antineoplastic (carcinoma)
0,181  0,048  Antineoplastic (squamous cell carcinoma)
0,143  0,012  Ribonucleoside-diphosphate reductase inhibitor
0,174  0,044  Cell wall synthesis inhibitor
0,152  0,023  DNA directed RNA polymerase inhibitor
0,227  0,098  UGT1A9 substrate
0,194  0,065  Myocardial ischemia treatment
0,154  0,026  AMP-activated protein kinase stimulant
0,132  0,004  Inosine monophosphate dehydrogenase inhibitor
0,130  0,002  Adenosine A2b receptor agonist
0,160  0,039  Antihemorrhagic
0,225  0,105  Huntington's disease treatment
0,153  0,034  Expectorant
0,142  0,026  Uric acid excretion stimulant
0,170  0,058  Acetylcholine M1 receptor antagonist
0,151  0,040  Glutathione S-transferase substrate
0,129  0,020  CDK1/cyclin B1 inhibitor
0,115  0,008  Purinergic P2Y antagonist
0,128  0,022  Transcription factor NF kappa B stimulant
0,174  0,068  Phospholipase C inhibitor
0,183  0,077  Hepatoprotectant
0,206  0,101  Antineoplastic (liver cancer)
0,111  0,008  S-adenosyl-L-methionine decarboxylase inhibitor
0,142  0,043  Gout treatment
0,112  0,014  Phosphodiesterase VI inhibitor
0,217  0,119  UGT2B4 substrate
0,179  0,086  Sensitization
0,115  0,023  Purinergic P2X2 antagonist
0,257  0,166  CYP2C19 inhibitor
0,102  0,013  Protein kinase C beta inhibitor
0,142  0,053  Death-associated protein kinase 1 inhibitor
0,119  0,030  Histamine N-methyltransferase inhibitor
0,132  0,044  Mucolytic
0,090  0,005  Purinergic P2X4 antagonist
0,168  0,083  Antineoplastic (gastric cancer)
0,097  0,013  Gaucher disease treatment
0,083  0,002  Adenosine A2a receptor agonist
0,149  0,070  Corneal wound healing stimulator
0,129  0,052  Alcohol dehydrogenase substrate
0,218  0,143  AR expression inhibitor
0,100  0,025  T cell inhibitor
0,169  0,097  Antiarrhythmic
0,079  0,008  Thymidylate synthase inhibitor
0,076  0,004  Uridine phosphorylase inhibitor
0,087  0,017  Protein 50S ribosomal subunit inhibitor
0,071  0,002  Purinergic P2Y15 antagonist
0,073  0,004  Guanylate cyclase inhibitor
0,074  0,005  Purinergic P2X agonist
0,102  0,034  Hematopoietic
0,206  0,140  Antineoplastic (multiple myeloma)
0,189  0,123  Hypoglycemic
0,196  0,131  Antineoplastic (pancreatic cancer)
0,184  0,123  Acute neurologic disorders treatment
0,190  0,129  Antiprotozoal (Trypanosoma)
0,124  0,065  Growth stimulant
0,229  0,172  Histamine release inhibitor
0,193  0,137  Antineoplastic (sarcoma)
0,119  0,063  Transcription factor STAT6 inhibitor
0,059  0,004  Inosine monophosphate dehydrogenase 1 inhibitor
0,166  0,112  Antihypertriglyceridemic
0,087  0,033  Selectin antagonist
0,201  0,148  Antifungal
0,054  0,003  Purinergic P2 agonist
0,054  0,003  Purinergic receptor agonist
0,066  0,019  Adenine nucleotide translocase inhibitor
0,068  0,024  Postcoital contraceptive
0,046  0,003  Purinergic P2Y agonist
0,048  0,005  Inosine monophosphate dehydrogenase 2 inhibitor
0,054  0,011  Antibiotic Aminoglycoside-like
0,045  0,002  Purinergic P2Y1 agonist
0,067  0,024  Glucosylceramidase inhibitor
0,095  0,053  Triose-phosphate isomerase inhibitor
0,091  0,050  Antileprosy
0,042  0,002  O6-alkylguanine-DNA alkyltransferase inhibitor
0,133  0,093  Insulin secretagoues
0,167  0,128  Platelet antagonist
0,062  0,024  Alpha-mannosidase inhibitor
0,048  0,011  HCV NS5B polymerase inhibitor
0,142  0,106  Hearing loss treatment
0,130  0,095  MAP3K9 inhibitor
0,046  0,012  Purinergic P2Y2 antagonist
0,054  0,021  Mannosidase inhibitor
0,046  0,013  CF transmembrane conductance regulator antagonist
0,034  0,002  Methylmalonyl-CoA mutase inhibitor
0,079  0,048  Antibiotic
0,041  0,010  Purinergic P2T antagonist
0,166  0,135  Antineoplastic (non-small cell lung cancer)
0,144  0,113  UGT2B10 substrate
0,070  0,039  Purinergic P2 antagonist
0,056  0,026  Antibiotic Glycopeptide-like
0,130  0,099  Restenosis treatment
0,054  0,024  Glucose-6-phosphate isomerase inhibitor
0,034  0,004  Isoleucine-tRNA ligase inhibitor
0,037  0,010  Purinergic P2Y12 antagonist
0,028  0,001  Purinergic P2Y2 agonist
0,161  0,136  Antihypercholesterolemic
0,208  0,185  Stroke treatment
0,033  0,009  Sodium/glucose cotransporter inhibitor
0,135  0,112  Nitric oxide antagonist
0,079  0,056  Phosphodiesterase 3A inhibitor
0,031  0,010  Sodium/glucose cotransporter 1 inhibitor
0,079  0,058  Antineoplastic antibiotic
0,042  0,021  Arginase inhibitor
0,045  0,030  Phosphodiesterase 3B inhibitor
0,121  0,106  Antiviral (Influenza A)
0,090  0,076  Sulfotransferase substrate
0,029  0,014  Sodium/glucose cotransporter 2 inhibitor
0,039  0,025  Antiviral (Bovine viral diarrhea virus)
0,153  0,140  MAP kinase kinase 5 inhibitor
0,121  0,107  Antiprotozoal (Coccidial)
0,130  0,117  CF transmembrane conductance regulator agonist
0,123  0,110  NOS3 expression enhancer
0,162  0,150  Vascular (periferal) disease treatment
0,076  0,064  Protein kinase A inhibitor
0,087  0,076  Lanosterol 14 alpha demethylase inhibitor
0,058  0,049  CDK1/cyclin B inhibitor
0,136  0,128  Aldehyde oxidase substrate
0,077  0,069  Antiviral (RSV)
0,160  0,153  Antioxidant
0,007  0,001  Purinergic P2Y6 agonist
0,032  0,027  RNA-directed RNA polymerase inhibitor
0,124  0,118  Antifungal (Cryptococcus)
0,181  0,176  Hepatic disorders treatment
0,086  0,081  Alpha 2d adrenoreceptor antagonist
0,037  0,033  Toll-Like receptor 2 agonist
0,015  0,012  Purinergic P2Y1 antagonist
0,067  0,065  NAD(P)H dehydrogenase (quinone) inhibitor
0,005  0,003  Purinergic P2Y4 agonist
0,147  0,146  Antiglaucomic

